You're going to hear a lot more about "aspirin resistance"
You're going to hear a lot more about "aspirin resistance."
Now that millions of people take low-dose aspirin to prevent cardiovascular disease, we're seeing that it doesn't always work.
About 10% of the population might be resistant to aspirin's antiplatelet effects. These patients might be up to 3 times more likely to have a heart attack or stroke.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote